Current role
Kirk V. Shepard, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kirk V. Shepard, M.D.
PDS Biotechnology Corp reported in an 8-K filed January 22, 2024 that Kirk V. Shepard, M.D. was appointed Chief Medical Officer, effective January 22, 2024.
“On January 22, 2024, the Company issued a press release announcing the retirement of Lauren V. Wood, M.D. and the appointment of Kirk V. Shepard, M.D. as Chief Medical Officer of the Company, in each case, effective as of January 22, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
PDS Biotechnology Corp (PDSB)
SEC 8-K
Current2024-01-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at PDS Biotechnology Corp
Other people whose current roles at this company are on record from its filings.
- Frank Bedu-Addo CEO, CFO, Board Member
- Lars Boesgaard CFO, Chief Accounting Officer
- Seth L. Van Voorhees CFO
- Seth L. Van Voorhees, Ph.D. CFO
- Seth Van Voorhees CFO
- Stephan F. Toutain COO
- Spencer Brown General Counsel
- Janetta Trochimiuk Chief Accounting Officer
- Dr. Patrick Soon-Shiong Board Member
- Frank Bedu-Addo, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.